Evidence map›Paper›PMID 36531184›Full record

ArticleFrontiers in physiology2022

Endothelial deletion of the cytochrome P450 reductase leads to cardiac remodelling.

Melina Lopez, Pedro F Malacarne, Deepak P Ramanujam, Timothy Warwick, Niklas Müller, Jiong Hu, Matthias Dewenter, Andreas Weigert, Stefan Günther, Ralf Gilsbach and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Melina LopezInstitute for Cardiovascular Physiology, Goethe-University, Frankfurt, Germany.
Pedro F MalacarneInstitute for Cardiovascular Physiology, Goethe-University, Frankfurt, Germany.
Deepak P RamanujamInstitute of Pharmacology and Toxicology, Technical University, Munich, Germany.
Timothy WarwickInstitute for Cardiovascular Physiology, Goethe-University, Frankfurt, Germany.
Niklas MüllerInstitute for Cardiovascular Physiology, Goethe-University, Frankfurt, Germany.
Jiong HuGerman Center of Cardiovascular Research (DZHK), Frankfurt, Germany.
Matthias DewenterInstitute of Experimental Cardiology, Heidelberg, Germany.
Andreas WeigertInstitute of Biochemistry I, Goethe University, Frankfurt, Germany.
Stefan GüntherMax-Planck-Institute for Heart and Lung Research, Bad Nauheim, Germany.
Ralf GilsbachInstitute for Cardiovascular Physiology, Goethe-University, Frankfurt, Germany.
Stefan EngelhardtInstitute of Pharmacology and Toxicology, Technical University, Munich, Germany.
Ralf P BrandesInstitute for Cardiovascular Physiology, Goethe-University, Frankfurt, Germany.
Flávia RezendeInstitute for Cardiovascular Physiology, Goethe-University, Frankfurt, Germany.
German Centre for Cardiovascular Research · DEGoethe University Frankfurt · DEMax Planck Institute for Heart and Lung Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cytochrome P450 reductase (POR) transfers electrons to all microsomal cytochrome P450 enzymes (CYP450) thereby driving their activity. In the vascular system, the POR/CYP450 system has been linked to the production of epoxyeicosatrienoic acids (EETs) but also to the generation of reactive oxygen species. In cardiac myocytes (CMs), EETs have been shown to modulate the cardiac function and have cardioprotective effects. The functional importance of the endothelial POR/CYP450 system in the heart is unclear and was studied here using endothelial cell-specific, inducible knockout mice of POR (ecPOR

Indexed as

cardiac myocytescardiac remodellingcytochrome P450 reductaseechocardiographyendothelial cellstransverse aortic constriction

Identifiers

PMID36531184
PMCPMC9755668
OpenAlexW4311186302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.